David A. Siegel Zai Lab LTD Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q3 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Zai Lab LTD stock. As of the latest transaction made, Two Sigma Advisers, LP holds 14,000 shares of ZLAB stock, worth $376,460. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,000Holding current value
$376,460% of portfolio
0.0%Shares
10 transactions
Others Institutions Holding ZLAB
# of Institutions
121Shares Held
46.7MCall Options Held
223KPut Options Held
588K-
Janus Henderson Group PLC London, X08.76MShares$236 Million0.11% of portfolio
-
Wellington Management Group LLP Boston, MA8.44MShares$227 Million0.04% of portfolio
-
Capital World Investors Los Angeles, CA6.44MShares$173 Million0.02% of portfolio
-
Viking Global Investors LP1.95MShares$52.4 Million0.18% of portfolio
-
Bamco Inc New York, NY1.91MShares$51.3 Million0.13% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $2.63B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...